Evidence map›Paper›PMID 39949623›Full record

ArticleFrontiers in microbiology2025

Pediatric kidney transplant recipients are at an increased risk for dysbiosis.

Gizem Yılmaz, Seha Saygılı, Ayşe Ağbaş, Esra Karabağ Yılmaz, Ahmet Variş, Nur Canpolat

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gizem YılmazDepartment of Pediatrics, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Türkiye.
Seha SaygılıDepartment of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Türkiye.
Ayşe AğbaşDepartment of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Türkiye.
Esra Karabağ YılmazDepartment of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Türkiye.
Ahmet VarişDiagen Biotechnology, Ankara, Türkiye.
Nur CanpolatDepartment of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to compare the gut microbiota composition in pediatric kidney transplant (KTx) recipient with that of healthy children. Methods: This cross-sectional observational study included 30 pediatric KTx recipients aged between 7 and 21 years and 25 healthy children. The gut microbiota was assessed using 16S rRNA gene sequencing, with alpha and beta diversity, as well as all statistical analyses, conducted using the Phyloseq library in the R programming language. Taxonomic profiles were evaluated with QIIME2, and differences in gut microbiota profiles were compared using linear discriminant analysis effect size (LEFSe) with an LDA threshold of >2 and Results: No significant differences were found in alpha and beta diversity between the KTx recipients and healthy controls. However, KTx recipients exhibited significant alterations in microbiota composition, including higher relative abundances of Verrucomicrobiota at the phylum level, and Akkermansia and Neisseria at the genus level ( Discussion: Pediatric KTx recipients demonstrated significant alterarions in gut microbiota composition, indicating dysbiosis. Further studies are needed to elucidate the cause-and-effect relationships of these changes and their impact on clinical consequencies and long-term prognosis.

Indexed as

childrendysbiosisgutintestinekidney transplantationmicrobiota

Identifiers

PMID39949623
PMCPMC11823477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.